US2011044956A1PendingUtilityA1
Nell-1 enhanced bone mineralization
Est. expiryOct 5, 2019(expired)· nominal 20-yr term from priority
Inventors:Kang Ting
A61K 38/1709G01N 33/6893C07K 14/51C12Q 1/6818A61K 48/00A61L 27/227A61P 19/08G01N 2333/51A61L 27/54A61L 27/58A61L 2300/252A61L 2430/02
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention pertains to the discovery that the human NELL-1 gene induces or upregulates bone mineralization. The NELL-1 gene or gene product thus provides a convenient target for screening for modulators of bone mineralization. In addition, NELL-1 can be used to facilitate repair of bone fractures and/or to generally increase bone density.
Claims
exact text as granted — not AI-modified1 . A method of facilitating the repair of bone fractures, the method comprising increasing concentration of a NELL-1 gene product at or near the fracture site.
2 . The method of claim 1 , where the NELL-1 gene product is increased in an osteogenic or bone precursor cell present at or near the fracture site.
3 . The method of claim 1 , comprising introducing an osteogenic cell or bone precursor cell that overexpresses NELL-1 into the fracture site.
4 . The method of claim 2 , comprising increasing the concentration of a NELL-1 gene product in the osteogenic cell or the bone precursor cell in situ
5 . The method of claim 2 , wherein the increasing the concentration of NELL-1 gene product comprises upregulating expression of a NELL-1 gene in the osteogenic cell.
6 . The method of claim 2 , wherein the upregulating comprises upregulating expression of an endogenous NELL-1 gene in the osteogenic cell.
7 . The method of claim 5 , wherein the upregulating comprises transfecting the cell with a vector that expresses a NELL-1 protein.
8 . The method of claim 7 , wherein the vector constitutively expresses a NELL-1 protein.
9 . The method of claim 7 , wherein expression of a NELL-1 protein by the vector is inducible.
10 . The method of claim 1 , wherein the increasing the concentration of NELL-1 gene product comprises contacting the cell with a NELL-1 polypeptide.
11 . The method of claim 2 , wherein the osteogenic cell is selected from the group consisting of a mature osteoblast, osteoblast, a mesenchymal cell, a fibroblast cell, a fetal embryonic cells, a stem cells, a bone marrow cell, a dura cell, a chrondrocyte, and a chondroblast.
12 . The method of claim 1 , wherein the NELL-peptide is encoded by a sequence of SEQ ID NO: 1 or SEQ ID NO: 2.
13 . A method of facilitating the repair of a bone fracture, the method comprising contacting the bone fracture site with a NELL-1 protein.
14 . The method of claim 13 , wherein the NELL-1 protein is combined with a collagen.
15 . The method of claim 13 , wherein the NELL-peptide is encoded by a sequence of SEQ ID NO: 1 or SEQ ID NO: 2.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.